Metralindole
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | 53734-79-5 |
| PubChem (CID) | 68713 |
| ChemSpider | 61964 |
| UNII |
2QW3FL6OPA |
| Chemical and physical data | |
| Formula | C15H17N3O |
| Molar mass | 255.32 g/mol |
| 3D model (Jmol) | Interactive image |
| |
Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.
See also
References
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
